EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Editorial: Cellular and molecular mechanisms of lung regeneration, repair, and fibrosis, volume II

Yong Qiu, Xiao Xiao Tang, Shigeyuki Shichino, Prem Prakash Kushwaha, Yan Y Sanders, Remo Castro Russo, Chunheng Mo

Frontiers in Cell and Developmental Biology · 12.08.2025 · 13

DOI: 10.3389/fcell.2025.1653034 ↗

Kurz gefasst

Editorial in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.08.2025. Verfasst von Yong Qiu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University H…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[Introduction] Organ fibrosis represents a substantial a major contributor to global disease burden, implicated in over 30% of cases leading to disability-associated and fatal conditions. Among these conditions, idiopathic pulmonary fibrosis (IPF) stands as a progressive and frequently fatal interstitial lung disease characterized by aberrant extracellular matrix deposition and parenchymal scarring. The prognosis for IPF patients is poor, with a median survival time of just 3–5 years (Bhattacharya and Ramachandran, 2023; Lederer and Martinez, 2018, Ma et al., 2024, Wei et al., 2024). Current FDA-approved therapeutics, Pirfenidone and Nintedanib, demonstrate capacity to attenuate functional decline in pulmonary fibrosis but remain disease-modifying rather than curative. Consequently, elucidating the underlying cellular and molecular mechanisms while developing more effective treatments constitutes an imperative research priority (Bonella et al., 2023, Podolanczuk et al., 2023, Zhang et al., 2023, Zhou et al., 2024).

Schlagwörter

Stichwörter der Autor:innen

asthmabronchopulmonary dysplasiachronic obstructive pulmonary diseaselung fibrosislung regeneration

Autor:innen und Institutionen

  • Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Department of Anesthesiology, Zigong First People's Hospital, Zigong Academy of Medical Sciences, Zigong, Sichuan, China.
  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital…
  • Guangzhou Laboratory, Guangzhou, China.
  • Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute of Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • School of Medicine, Case Western Reserve University, Cleveland, United States.

Zitieren

APA

Qiu, Y., Tang, X. X., Shichino, S., Kushwaha, P. P., Sanders, Y. Y., Russo, R. C., & Mo, C. (2025). Editorial: Cellular and molecular mechanisms of lung regeneration, repair, and fibrosis, volume II. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1653034

Vancouver

Qiu Y, Tang XX, Shichino S, Kushwaha PP, Sanders YY, Russo RC, et al. Editorial: Cellular and molecular mechanisms of lung regeneration, repair, and fibrosis, volume II. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1653034

BibTeX
@article{Qiu2025,
  author = {Qiu, Yong and Tang, Xiao Xiao and Shichino, Shigeyuki and Kushwaha, Prem Prakash and Sanders, Yan Y and Russo, Remo Castro and Mo, Chunheng},
  title = {Editorial: Cellular and molecular mechanisms of lung regeneration, repair, and fibrosis, volume II},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1653034}
}
Kostenlos starten →